PharmaCielo

Toronto, Canada Founded: 2014 • Age: 12 yrs Listed
Medicinal cannabis oil and products are produced in Colombia.

About PharmaCielo

PharmaCielo is a publicly listed company based in Toronto (Canada) founded in 2014. Medicinal cannabis oil and products are produced in Colombia. PharmaCielo has raised $16.44 million across 10 funding rounds. PharmaCielo has completed 2 acquisitions, including Creso Pharma and Ubiquo Telemedicina. Its chief executive, as recorded, is Marc Lustig. PharmaCielo offers products and services including CBD Isolate, Medicinal Flower, and Cannabis Extracts. Its focus areas include Food and Agriculture Tech, Crop Tech, Indoor Farming and Hydroponics. Its competitors include Canopy Growth, Organigram and Cannara Biotech; 1 of its 3 listed competitors has raised funding.

Company details

PharmaCielo was founded in 2014 and is headquartered in Toronto, Canada. Operations focus on the cultivation and marketing of medicinal cannabis in Colombia, where proprietary strains are grown under controlled indoor environments. Cannabis flowers are processed to extract oil and manufacture pharmaceutical-grade products for the health sector.

  • Headquarters Toronto, Canada
  • Stage Public
  • Sectors
    Agriculture
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pharmacielo.com
  • Social LinkedIn X Instagram YouTube
  • Legal Name Pharmacielo Ltd.
Operational Areas
Key Metrics
  • Annual Revenue
    $1.82 M (USD)
    -17.31
    as on Mar 31, 2026
  • Net Profit
    -$2.57 M (USD)
    59.3
    as on Mar 31, 2026
  • EBITDA
    -$1.79 M (USD)
    22.46
    as on Mar 31, 2026
  • Total Equity Funding
    $16.44M (USD)

    in 10 rounds

  • Latest Funding Round
    $10M (USD), Post-IPO

    Nov 2020

  • Investments & Acquisitions

Products & Services of PharmaCielo

PharmaCielo offers a comprehensive portfolio of products and services, including CBD Isolate, Medicinal Flower, and Cannabis Extracts.

CBD Isolate
Cannabis Extract

Pure CBD refined for precise medicinal and pharmaceutical applications.

Medicinal Flower
Cannabis Product

High-quality cannabis flower grown for reliable pharmaceutical use.

Cannabis Extracts
Biotech Product

Processed extracts for consistent, safe medicinal applications.

Apps and channels of PharmaCielo

its YouTube channel PharmaCielo Ltd. has 261 subscribers and 9 videos.

PharmaCielo Ltd.
YouTube 261 subscribers 9 videos Science & Technology
Open channel

Videos from PharmaCielo

The most watched videos on PharmaCielo's YouTube channel, PharmaCielo Ltd. (261 subscribers). Click a video to play it here.

Welcome to PharmaCielo
6.5K views
PharmaCielo Facility Tour
1.3K views
Bienvenido a PharmaCielo
708 views
Our People
632 views

More on PharmaCielo Ltd..

Funding Insights of PharmaCielo

PharmaCielo has successfully raised a total of $16.44M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $10 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $16.44M
  • Total Rounds 10
  • Last Round Post-IPO β€” $10M
  • First Round $686,250

    (May 2015)

All 10 funding rounds of PharmaCielo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2020$10MPost-IPO––
–
Apr 2020$5.64MPost-IPO––
–
Feb 2019$6.32MPost-IPO––
–
Dec 2017$1.96MSeries A––
–
Jul 2017$2.96MSeries A––
–
May 2017$3.71MSeries A––
–
Jun 2016$116,500Series A––
–
May 2016$4.02MSeries A––
–
Feb 2016$2.98MSeries A––
–
May 2015$686,250Seed––
–

People of PharmaCielo

20 people are tracked at PharmaCielo (8 in leadership, 2 in board & advisors, 10 in team).

NameRoleGroup
Marc Lustig
CEOLeadership
Andrés Felipe Botero
Chief Operating Officer, PharmaCielo ColombiaLeadership
Bill Petron
CEO & Chairman of the BoardLeadership
Ian D. Atacan
Chief Financial OfficerLeadership
Delon H.
President, Global Head Health & InnovationLeadership
Juan Camilo Esguerra
Chief Legal Officer And Vice President Of Government AffairsLeadership
Andres Felipe Botero Diaz
Chief Operating OfficerLeadership
Pablo Cuartas
Head Of Operations PlanningLeadership
Doug Bache
Director & Audit Committee ChairBoard & advisors
Will Nicholas
DirectorBoard & advisors
María Cristina Gil González
Operaria IndustrialTeam
Henning von Koss
Unknown RoleTeam
Oscar Eduardo Soto Castañeda
Ingeniero De MantenimientoTeam
Luisa Fernanda Serna Cárdenas
Jefe De Control InternoTeam
Mabel Manrique Garcia
Coordinadora De ProcesosTeam
Maria Camila Velez
Jefe De LogísticaTeam
Carmenza Patiño
Analista De ComprasTeam
Robert Gavidge
Finance AnalystTeam
Luis Felipe Vidal Jiménez
Jefe De Planeación FinancieraTeam
Jose Pablo Saldarriaga Franco
Supply Chain ManagerTeam
Premium access

Complete people profiles for PharmaCielo

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of PharmaCielo

PharmaCielo is a publicly listed company on the OTC with ticker symbol PCLOF in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date02 Feb 2018
  • Listed onTSX-V: PCLO
  • Listed entityPHARMACIELO LTD.
  • Exchange sectorProcess industries
  • ISINCA71716K1012
  • Share price$0.04 (+21.79% on the day) · 2026-05-11
  • Market capitalisation$6.8M
  • EPS (diluted, trailing year)$-0.02
  • Volume (last session)10,000
  • Analyst consensusNo rating

Financials of PharmaCielo

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$1.8M-$2.6M-$1.8M
2024$2.2M-$6.3M-$2.3M
2023$1.2M-$12.3M-$6.9M
2022$3.9M-$10.7M-$6.3M
2021$1.5M-$21.1M-$17.8M
Premium access

Detailed financial statements for PharmaCielo

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PharmaCielo

PharmaCielo has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Creso Pharma and Ubiquo Telemedicina.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Cannabinoid therapeutics are developed for human and veterinary health applications.
cresopharma.comPerth, Australia2015Jun 2019$85.2M
Web platforms for telemedicine, workflow, and image management are provided.
ubiquotelemedicina.com.coMedellin, Colombia2010Apr 2018$1.19M
Premium access

Complete acquisition details for PharmaCielo

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of PharmaCielo

6 dated milestones of PharmaCielo across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded PharmaCielo is founded.
  2. Funding First funding round of $686K.
  3. IPO Lists on the stock exchange (IPO).
  4. Acquisition Acquires Ubiquo Telemedicina.
  5. Acquisition Acquires Creso Pharma.
  6. Funding Latest funding round, Post-IPO, of $10.0M.

Competitors of PharmaCielo

PharmaCielo has 3 listed competitors in our database, 1 of them funded. They include Canopy Growth, Organigram and Cannara Biotech.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
canopygrowth.com2013Smiths Falls, Canada170
Cannabis products are provided to support consumer wellness and health.
organigram.ca2013Moncton, Canada
Provider of cannabis products, brands, and international business development investments
cannara.ca2018Montreal, Canada$17.66M
Medicinal cannabis cultivation facility
Premium access

Detailed competitors of PharmaCielo

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pharmacielo

Premium access

Complete news archive for PharmaCielo

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PharmaCielo

PharmaCielo was founded in 2014 and raised its 1st funding round 1 year after it was founded.

PharmaCielo is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Marc Lustig is the CEO of PharmaCielo, as recorded in our data.

PharmaCielo is a funded company, having raised a total of $16.44M across 10 funding rounds to date. The company's 1st funding round was a Seed of $686.25K, raised on May 2015.

Annual revenue of PharmaCielo is $1.82M as on Mar 31, 2026.

PharmaCielo was founded in 2014 and is headquartered in Toronto, Canada. Operations focus on the cultivation and marketing of medicinal cannabis in Colombia, where proprietary strains are grown under controlled indoor environments. Cannabis flowers are processed to extract oil and manufacture pharmaceutical-grade products for the health sector.

PharmaCielo's top competitors include Canopy Growth, Organigram and Cannara Biotech.

PharmaCielo offers CBD Isolate, Medicinal Flower, and Cannabis Extracts.

Yes, PharmaCielo is publicly traded on OTC under the ticker symbol PCLOF.

PharmaCielo has made 2 acquisitions, including Creso Pharma, and Ubiquo Telemedicina.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available